These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 19644356

  • 1. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
    Park CY.
    Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.
    Josephs D, Hutson TE, Cowey CL, Pickering LM, Larkin JM, Gore ME, Van Hemelrijck M, McDermott DF, Powles T, Chowdhury P, Karapetis C, Harper PG, Choueiri TK, Chowdhury S.
    BJU Int; 2011 Oct; 108(8):1279-83. PubMed ID: 21244613
    [Abstract] [Full Text] [Related]

  • 3. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
    Vickers MM, Heng DY, Hemmelgarn B, Eigl BJ.
    Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
    [Abstract] [Full Text] [Related]

  • 4. Treatment of hemodialyzed patients with sunitinib in renal cell carcinoma.
    Park S, Lee J, Park SH, Park JO, Kang WK, Park YS, Cho JH, Lim HY.
    Chemotherapy; 2010 Oct; 56(6):485-91. PubMed ID: 21099221
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency.
    Kim KH, Kim HY, Kim HR, Sun JM, Lim HY, Lee HJ, Lee S, Bae WK, Rha SY, Korean Cancer Study Group, Genitourinary & Gynecology Cancer Committee.
    Eur J Cancer; 2014 Mar; 50(4):746-52. PubMed ID: 24332573
    [Abstract] [Full Text] [Related]

  • 6. Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors.
    Adams VR, Leggas M.
    Clin Ther; 2007 Jul; 29(7):1338-53. PubMed ID: 17825686
    [Abstract] [Full Text] [Related]

  • 7. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
    De Vincenzo F, Zucali PA, Ceresoli GL, Colombo P, Simonelli M, Lorenzi E, Perrino M, Gianoncelli L, De Sanctis R, Graziotti P, Santoro A.
    J Clin Oncol; 2011 Jun 20; 29(18):e529-31. PubMed ID: 21483010
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinoma.
    Diekstra MH, Swen JJ, Boven E, Castellano D, Gelderblom H, Mathijssen RH, Rodríguez-Antona C, García-Donas J, Rini BI, Guchelaar HJ.
    Eur Urol; 2015 Oct 20; 68(4):621-9. PubMed ID: 25930089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma.
    Brunello A, Saia G, Bedogni A, Scaglione D, Basso U.
    Bone; 2009 Jan 20; 44(1):173-5. PubMed ID: 18849018
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
    Aksu G, Ensaroglu F, Dolasik I, Temiz S, Halis H, Sener SY, Kaya A, Uygun K.
    J BUON; 2010 Jan 20; 15(4):798-9. PubMed ID: 21229650
    [No Abstract] [Full Text] [Related]

  • 15. Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience.
    Coelho RC, Reinert T, Campos F, Peixoto FA, de Andrade CA, Castro T, Herchenhorn D.
    Int Braz J Urol; 2016 Jan 20; 42(4):694-703. PubMed ID: 27564279
    [Abstract] [Full Text] [Related]

  • 16. Sunitinib for the management of advanced renal cell carcinoma.
    Escudier B.
    Expert Rev Anticancer Ther; 2010 Mar 20; 10(3):305-17. PubMed ID: 20214511
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperlipidemia and hypothyroidism among metastatic renal cell carcinoma patients taking sunitinib malate. Related or unrelated adverse events?
    Tassi R, Baldazzi V, Lapini A, Carini M, Mazzanti R.
    Clin Genitourin Cancer; 2015 Apr 20; 13(2):e101-5. PubMed ID: 25450040
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.